Hi [[ session.user.profile.firstName ]]

Thrombotic Thrombocytopenic Purpura and ADAMTS13

This webinar will focus on Thrombotic Thrombocytopenic Purpura (TTP) laboratory testing and management. Dr. Flora Peyvandi, an expert in coagulation disorders, will provide an overview of TTP, discuss the role of the von Willebrand factor cleaving protein, ADAMTS13, in TTP diagnosis and monitoring; and review ADAMTS13 laboratory testing method and propose opportunities for improved TTP management.
Recorded Feb 19 2020 38 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Flora Peyvandi, MD, PhD
Presentation preview: Thrombotic Thrombocytopenic Purpura and ADAMTS13

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • Thrombotic Thrombocytopenic Purpura and ADAMTS13 Recorded: Feb 19 2020 38 mins
    Flora Peyvandi, MD, PhD
    This webinar will focus on Thrombotic Thrombocytopenic Purpura (TTP) laboratory testing and management. Dr. Flora Peyvandi, an expert in coagulation disorders, will provide an overview of TTP, discuss the role of the von Willebrand factor cleaving protein, ADAMTS13, in TTP diagnosis and monitoring; and review ADAMTS13 laboratory testing method and propose opportunities for improved TTP management.
  • Vizient Webinar: Monitoring Extended Half-Life Factor Products Recorded: Jan 15 2020 54 mins
    Melissa Bethel, MT(ASCP) Clinical Hemostasis Specialist, Instrumentation Laboratory
    As part of the ILluminations Webinar Series, Instrumentation Laboratory invites you to a webinar about a major advance in the field of hemophilia care: modified factor VIII and IX products with extended half-lives (EHLs). Melissa Bethel, Clinical Hemostasis Specialist at IL, will discuss how these modified products may require different laboratory assays to accurately measure their effectiveness in hemophilia patients.
  • Antiphospholipid Syndrome: the Role of Anti-ß2Glycoprotein-I IgG Domain I Recorded: Dec 12 2018 36 mins
    Dr. Vittorio Pengo
    As part of the ILiuminations Webinar Series, Instrumentation Laboratory
    invites you to a webinar about Antiphospholipid Syndrome (APS) and the
    role of "non-criteria" antiphospholipid antibodies. Vittorio Pengo, MD, a widely published expert on thrombotic and bleeding disorders, will review current APS classification criteria and new markers under investigation, with a focus on the anti-β2Glycoprotein-l lgG Domain I, its role in APS management, and application in the Hemostasis laboratory.
  • Implementing ROTEM-guided Bleeding Management as part of a PBM program Recorded: Jul 25 2018 60 mins
    Bronwyn Pearse, RN, MClinPract
    Clinicians must use evidence-based best practices to deliver high quality care for optimal outcomes. This is crucial to prevent unnecessary treatment or treatment that could potentially be harmful to patients.

    However, implementing evidence-based Bleeding Management can be challenging. The use of evidence-based “planned change models” offers a foundation for applying the lessons learned through research, from one clinical context to another. Research demonstrates that theory-based implementation provides an increased likelihood of successful practice change versus an ad hoc approach.

    In this webinar, Bronwyn Pearse will review how one institution implemented a Bleeding Management program, including both successes and challenges. She will provide an overview of the role of evidence-based implementation and the benefits of planned change models. And she will offer strategies for implementing a Bleeding Management program in your institution as a part of a PBM program, including the use of ROTEM testing.
  • Current Issues in VWD Diagnosis and Management Recorded: Dec 13 2017 55 mins
    Alberto Tosetto, MD
    As part of the ILluminations Webinar Series, Instrumentation Laboratory invites
    you to a webinar on von Willebrand disease (VWD) diagnosis and management.
    Alberto Tosetto, MD, a widely published expert on thrombotic and bleeding
    disorders, will cover VWD etiology; laboratory investigation to differentiate VWD
    subtypes; potential improvements in VWD, including standardization and
    treatment; and a practical approach to screening and testing for VWD diagnosis.
  • Patient Blood Management: Improving Outcomes and Lowering Costs Recorded: Nov 16 2017 60 mins
    Axel Hofmann, ME
    In this webinar, PBM expert Axel Hofmann, ME, will provide an overview
    of PBM—what it is and why it is important to hospitals, physicians and
    patients. Dr. Hofmann will discuss how PBM can address the challenges
    of healthcare today and lead to both improved patient outcomes and
    lower cost of care. Last, he will describe how viscoelastic testing fits into
    the PBM concept.
  • Detection and Reduction of Transient Errors to Manage Risk in POCT Recorded: Oct 25 2017 55 mins
    James H. Nichols, PhD, DABCC, FACB
    This webinar will focus on risk management and the value of detecting transient or random sample errors in point-of care testing. Additionally, clinical advantages of IntraSpect™ technology on the new GEM® Premier™ 5000 system with Intelligent Quality Management 2 (iQM®2) will be discussed.
  • Age-Adjusted D-Dimer Cut-off Values for VTE Exclusion Recorded: Dec 15 2016 52 mins
    Pierre Toulon, PharmD, PhD
    As part of the ILluminations Webinar Series, Instrumentation Laboratory invites you to attend a webinar that examines the implementation of age-adjusted cut-off levels when using D-Dimer measurement to exclude venous thromboembolism (VTE) in diagnosis. Professor Toulon, a renowned expert on VTE diagnosis, will show how using age-adjusted cut-off levels for the HemosIL D-Dimer assay in patients over 50 yields increased specificity for the safe exclusion of VTE, and how this strategy can improve clinical and economic outcomes.
  • Changes, Challenges and Compliance in Point-of-Care Testing Recorded: Dec 7 2016 62 mins
    Kim Skala, MT (ASCP)
    In this valuable webinar, Ms. Skala will identify the problems, challenges
    and regulatory changes laboratory professionals face today, including:
    • Personnel turnover
    • The rate of diagnostic error
    • Risk assessment and management
    • Procurement procedures
    • CAP, CMS, CLIA, COLA and Joint Commission guidelines and changes
    • Integrating a Triple Aim strategy
    She will then present valuable resources to help you manage your challenges and comply with regulatory changes. Such resources include the ECRI Institute, IL Risk Management Training Programs, the IQCP Resource Guide, and the CDC.
    You will leave with up-to-date knowledge on recent regulatory changes, and more confidence in managing your challenges through a variety of helpful resources.

    Participant Event Plus Toll Free Dial-In Number:
    (855) 590-2904

    Participant Event Plus Toll Dial-In Number:
    (414) 238-0754
  • Laboratory Testing for Patients on Direct Oral Anticoagulants Recorded: Nov 12 2015 60 mins
    Dr. Armando Tripodi
    Direct Oral Anticoagulants (DOACs) have become widely prescribed. Clinical indications of DOACs include stroke prevention in non-valvular atrial fibrillation, thromboprophylaxis following hip or knee replacement surgery, and treatment or prevention of venous thromboembolic disease, among others.

    Although DOACs do not require routine monitoring, there are instances when determining DOAC concentration in the blood can be useful in ensuring optimal patient care.

    In this ILluminations Webinar, Dr. Tripodi will describe the primary characteristics of both “new” and “old” anticoagulant drugs, with a focus on the benefits of measuring DOAC concentration in certain clinical scenarios. He will elaborate on how to test for commercially available DOACs (e.g., dabigatran, rivaroxaban and apixaban), the alerting value ranges for DOAC concentrations, and how DOACs affect the most common hemostatic parameters.
Instrumentation Laboratory. Our Passion. Your Results.
ILluminations Webinars are educational, web-based seminars led by experts and opinion leaders. The Series features timely topics and clinical challenges that impact the effectiveness and success of healthcare.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Thrombotic Thrombocytopenic Purpura and ADAMTS13
  • Live at: Feb 19 2020 1:00 pm
  • Presented by: Flora Peyvandi, MD, PhD
  • From:
Your email has been sent.
or close